Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Fred Telling currently holds 34,538 shares of CELL THERAPEUTICS INC (CTIC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fred Telling has been a net buyer of CTIC stock. They have purchased $867.8K and sold $546.2K worth of shares.
Fred Telling's most recent insider trade was on Dec 12, 2025, when they sold 210 shares at $0.94 per share.
Fred Telling serves as Executive at CELL THERAPEUTICS INC (CTIC). They have executed 92 insider transactions totaling $1.4M over their tenure at the company.
Fred Telling holds the position of Executive at CELL THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Fred Telling has shown a buying trading pattern, with $867.8K in total purchases and $546.2K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Fred Telling was on Jun 30, 2016, when they purchased $504.0K worth of OGEN.BC shares. This transaction involved 969,180 shares at $0.52 per share.
Fred Telling currently owns 34,538 shares of CELL THERAPEUTICS INC (CTIC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Fred Telling's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Fred Telling has 92 Form 4 filings on record as an insider at CELL THERAPEUTICS INC.
Set alerts for Fred Telling and 40,000+ other insiders.